Prosecution Insights
Prosecution Insights
15 pending office actions • 11 art units • 12 examiners • 0 of 15 (0%) have an AI response strategy ready • 27 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (33%) |
| §102 only | 1 (7%) |
| §112 only | 2 (13%) |
| Double-patenting only | 2 (13%) |
| Double-patenting + other | 1 (7%) |
| Multi-statute (no §101) | 3 (20%) |
| No statute on record | 1 (7%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| POPA, ILEANA | 4 | 21.4% | +14.6% |
| CABRAL, ROBERT S | 1 | 62.6% | +32.4% |
| GROOMS, TIFFANY NICOLE | 1 | 58.8% | +46.8% |
| ZARA, JANE J | 1 | 70.9% | +16.1% |
| MOORE, JOHN DAVID | 1 | 65.4% | +23.5% |
| ANDERSON, REBECCA L | 1 | 73.3% | +23.8% |
| SINGH, ANOOP KUMAR | 1 | 42.8% | +67.4% |
| BRANDSEN, BENJAMIN MICHAEL | 1 | 60.4% | +18.3% |
| MITCHELL, EDWIN COLEMAN | 1 | 30.5% | +64.9% |
| LU, FRANK WEI MIN | 1 | 62.6% | +67.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18431597 | Liver Specific Delivery of Messenger RNA | POPA, ILEANA | 29d overdue |
| 18334330 | LIVER SPECIFIC DELIVERY OF MESSENGER RNA | POPA, ILEANA | 29d overdue |
| 17450629 | PROCESS OF PREPARING MRNA-LOADED LIPID NANOPARTICLES | POPA, ILEANA | 9d |
| 18890983 | STEREOCHEMICALLY ENRICHED COMPOSITIONS FOR DELIVERY OF NUCLEIC ACIDS | POPA, ILEANA | — |
| 18552165 | Optimized Nucleotide Sequences Encoding the Extracellular Domain of Human ACE2 Protein or a Portion Thereof | MOORE, JOHN DAVID | — |
| 18186856 | MRNA THERAPEUTIC COMPOSITIONS AND USE TO TREAT DISEASES AND DISORDERS | SINGH, ANOOP KUMAR | — |
| 17262421 | Dry Powder Formulations for Messenger RNA | HAGHIGHATIAN, MINA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18431597 | Liver Specific Delivery of Messenger RNA | POPA, ILEANA | 29d overdue |
| 18334330 | LIVER SPECIFIC DELIVERY OF MESSENGER RNA | POPA, ILEANA | 29d overdue |
| 18246263 | PIPERAZINE-BASED CATIONIC LIPIDS | ANDERSON, REBECCA L | 18d overdue |
| 17450629 | PROCESS OF PREPARING MRNA-LOADED LIPID NANOPARTICLES | POPA, ILEANA | 9d |
| 17534956 | Stable Liquid Lipid Nanoparticle Formulations | MITCHELL, EDWIN COLEMAN | 47d |
| 18890983 | STEREOCHEMICALLY ENRICHED COMPOSITIONS FOR DELIVERY OF NUCLEIC ACIDS | POPA, ILEANA | — |
| 18753746 | PROCESS OF PREPARING MRNA-LOADED LIPID NANOPARTICLES | CABRAL, ROBERT S | — |
| 18565849 | ASSAY FOR QUANTITATIVE ASSESSMENT OF MRNA CAPPING EFFICIENCY | GROOMS, TIFFANY NICOLE | — |
| Art Unit | Apps |
|---|---|
| 1633 | 3 |
| 1637 | 2 |
| 1614 | 1 |
| 1656 | 1 |
| 1626 | 1 |
| 1632 | 1 |
| 1693 | 1 |
| 1619 | 1 |
| 1683 | 1 |
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18890983 | STEREOCHEMICALLY ENRICHED COMPOSITIONS FOR DELIVERY OF NUCLEIC ACIDS | POPA, ILEANA | — | §103 | Non-Final OA | — | Pending | Sep 20, 2024 |
| 18753746 | PROCESS OF PREPARING MRNA-LOADED LIPID NANOPARTICLES | CABRAL, ROBERT S | 1614 | §102 | Non-Final OA | — | Pending | Jun 25, 2024 |
| 18431597 | Liver Specific Delivery of Messenger RNA | POPA, ILEANA | 1633 | Other | Final Rejection | 29d overdue | Pending | Feb 02, 2024 |
| 18565849 | ASSAY FOR QUANTITATIVE ASSESSMENT OF MRNA CAPPING EFFICIENCY | GROOMS, TIFFANY NICOLE | 1637 | §112 | Non-Final OA | — | Pending | Nov 30, 2023 |
| 18286029 | IMPROVED COMPOSITIONS FOR DELIVERY OF MRNA | ZARA, JANE J | 1637 | DP | Non-Final OA | — | Pending | Oct 06, 2023 |
| 18552165 | Optimized Nucleotide Sequences Encoding the Extracellular Domain of Human ACE2 Protein or a Portion Thereof | MOORE, JOHN DAVID | 1656 | §103§112 | Non-Final OA | — | Pending | Sep 22, 2023 |
| 18334330 | LIVER SPECIFIC DELIVERY OF MESSENGER RNA | POPA, ILEANA | 1633 | §103Other | Final Rejection | 29d overdue | Pending | Jun 13, 2023 |
| 18246263 | PIPERAZINE-BASED CATIONIC LIPIDS | ANDERSON, REBECCA L | 1626 | DP | Final Rejection | 18d overdue | Pending | Mar 22, 2023 |
| 18186856 | MRNA THERAPEUTIC COMPOSITIONS AND USE TO TREAT DISEASES AND DISORDERS | SINGH, ANOOP KUMAR | 1632 | §103§112 | Non-Final OA | — | Pending | Mar 20, 2023 |
| 17871121 | METHODS FOR PURIFICATION OF MESSENGER RNA | BRANDSEN, BENJAMIN MICHAEL | 1693 | §103Other | Final Rejection | — | Pending | Jul 22, 2022 |
| 17534956 | Stable Liquid Lipid Nanoparticle Formulations | MITCHELL, EDWIN COLEMAN | 1619 | §103Other | Non-Final OA | 47d | Pending | Nov 24, 2021 |
| 17450629 | PROCESS OF PREPARING MRNA-LOADED LIPID NANOPARTICLES | POPA, ILEANA | 1633 | §103Other | Non-Final OA | 9d | Pending | Oct 12, 2021 |
| 17344535 | METHODS FOR PURIFICATION OF MESSENGER RNA | LU, FRANK WEI MIN | 1683 | §103§112DP | Non-Final OA | — | Pending | Jun 10, 2021 |
| 17291937 | 2,5-DIOXOPIPERAZINE LIPIDS WITH INTERCALATED ESTER, THIOESTER, DISULFIDE AND ANHYDRIDE MOIEITIES | AUDET, MAURY A | 1654 | §112 | Non-Final OA | 79d | Pending | May 06, 2021 |
| 17262421 | Dry Powder Formulations for Messenger RNA | HAGHIGHATIAN, MINA | 1616 | §103§112 | Non-Final OA | — | Pending | Jan 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial